- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Lithium heparin anticoagulant with 15-25 IU/mL dosage for clinical and emergency biochemistry testing |
| Catalog No. | ATR-SPS-0080 |
| Description | Lithium heparin is a fast-acting anticoagulant widely used across clinical laboratory medicine, from routine biochemistry to emergency diagnostics. It activates antithrombin III to neutralize thrombin and factor Xa, keeping blood liquid within seconds of collection. Heparinized plasma is well suited for electrolyte measurement, kidney and liver function panels, and cardiac marker assays, and typical dosing of 15-25 IU per milliliter of blood achieves reliable anticoagulation with minimal assay interference. |
| Intended Use | Anticoagulation of blood samples for clinical biochemistry, emergency laboratory testing, and coagulation monitoring in patients receiving anticoagulant therapy. |
| Principle / Technology | Enhances the activity of antithrombin III (ATIII), a natural plasma protease inhibitor, increasing its ability to neutralize coagulation factors—especially thrombin and factor Xa—so clotting is effectively prevented. |
| Sample Type | Whole blood, plasma |
| Storage Conditions | Store sealed in a cool, dry place |
| Shelf Life | 3 years |
| Product Form | Powder |
| Key Features | Rapid onset of anticoagulation keeps samples liquid for immediate processing; low interference with most biochemical analytes; well suited to time-critical emergency testing |
| Appearance | White to off-white powder |
| Solubility | Readily soluble in water |
| CAS Number | 9045-22-1 |
| Potency | ≥150 IU/mg |
| Dosage | Typically 15-25 IU of lithium heparin per mL of blood; adjust according to collection tube size, expected blood volume and the requirements of the test item |
| Physical Properties | Odorless; readily water-soluble; hygroscopic |
For research use only, not for clinical use.
|
There is no product in your cart. |